Form 4 for ACET Adicet Bio, Inc.
Accepted 2021-10-13 00:00:00 ET · period of report 2021-10-12 · accession 0001209191-21-060360 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-13 | 2021-10-12 | ACET | Aftab Blake | CSO | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 |
| D | 2021-10-13 | 2021-10-12 | ACET | Aftab Blake | CSO | A - Grant | $0.00 | +60.0K | 60.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-12 | A | A | 80,000 | $0.00 | 80,000 | D | — | — | (F1) The Reporting Person was issued Restricted Stock Units ("RSU"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in two (2) annual installments of 20% of the shares vesting, with the first tranche vesting on October 12, 2022 and the second tranche vesting on October 12, 2023. The remaining shares shall vest upon achievements of specific milestones outlined in the Reporting Persons Restricted Stock Unit Agreement. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance. |
| 2 | Derivative | Stock Option (right to Buy) | 2021-10-12 | A | A | 60,000 | $0.00 | 60,000 | D | $7.38 · — to 2031-10-11 | 60,000 Common Stock | (F2) 25% of the shares subject to the stock option shall vest on October 12, 2022, and the remainder of the shares shall vest in equal monthly installments for a period of 36 months thereafter, subject to continued service with the Company. |